EPO and chronic kidney disease: Anaemia of chronic kidney disease (CKD) is a common complication in patients undergoing haemodialysis (HD), mainly due to the reduced renal production of erythropoietin, and is associated with a reduced quality of life and poor prognosis in this setting [1,2].